Developmentaid logo
Register

Cellnovo concludes a loan agreement for up to EUR 20 million from the EIB

Jul 11, 2017
Cellnovo concludes a loan agreement for up to EUR 20 million from the EIB

Add us as your preferred source on Google to see more of our content in Search.

Google logoAdd to Preferred Sources

The European Investment Bank (EIB) and Cellnovo Group, a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, announce that they have concluded a loan agreement for €20 million to support Cellnovo in its transition to full industrial-scale operations.

The loan is supported by the European Fund for Strategic Investments (EFSI), which is the central pillar of the European Commission’s Investment Plan for Europe, the so-called “Juncker Plan”. Jointly launched by the EIB Group and the European Commission, the Juncker Plan aims to mobilise private investment in projects and sectors such as research and innovation which are strategically important for the European Union. It provides equity-type financing for early stage companies with high growth potential.

The EIB financing will be utilised by the Company to improve the design of the current Cellnovo System with the objective of reducing production costs. The investment will also finance additional production lines as well as multi-centre clinical trials of artificial pancreas solutions in order to obtain clinical data with a view to receiving market authorisations in the United States and Europe.

“EIB is very proud to be contributing to the success of Cellnovo through this new Juncker Plan financing.  The Juncker Plan is continuing to develop in France with 70 operations approved to-date, which are expected to generate €27,6bn of additional investment. This signature underlines our commitment to supporting the development of innovative, high value-added companies in Europe. Innovation, particularly in healthcare, is essential to the sustainability of companies, this is why it is a key priority for EIB to support them. In addition, we offer tailored financial products to enable innovative companies such as Cellnovo to pursue their strategy and development,” EIB Vice-President Ambroise Fayolle.

Source: EIB. Read full information.
11 July, 2017